Get in Touch

Identifying opportunities for boosting portfolio of products

Client Challenge

European biotech with a focus on pulmonology and neurology wished to identify opportunities to add to their portfolio in similar disease areas.

The client wanted recommendations about diseases areas for future investment that fit with its existing focus.

P4A Solution

P4A developed a specific set of criteria to identify and assess the relevant commercial opportunities:

  • Identification of target diseases
  • Commercial opportunity assessment
  • Primary research validation
We used a systematic approach to identifying target diseases through weighted scoring system. We also identified a shortlist of high scoring diseases for further secondary and primary research validation with KOLs

The Successful Outcome

  • Identified 25 rare diseases matching search criteria
  • Provided extensive information packs on each disease, focusing on key parameters including pipeline size and out-licensing potential
  • Understanding single drug vs platform for disease…
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact